These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32546626)

  • 41. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
    Li W; Anderson RA
    Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
    DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
    Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
    Diaz D; Santander MA; Chavez JA
    Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
    Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK
    Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16.
    Yi JW; Jang M; Kim SJ; Kim SS; Rhee JE
    Oncol Rep; 2013 Apr; 29(4):1617-22. PubMed ID: 23404471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines.
    Calmon MF; Sichero L; Boccardo E; Villa LL; Rahal P
    Virology; 2016 Sep; 496():35-41. PubMed ID: 27240147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
    Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53.
    Au Yeung CL; Tsang WP; Tsang TY; Co NN; Yau PL; Kwok TT
    Oncol Rep; 2010 Dec; 24(6):1599-604. PubMed ID: 21042757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
    Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
    Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Wang X; Meyers C; Guo M; Zheng ZM
    Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.
    Thatte J; Massimi P; Thomas M; Boon SS; Banks L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
    Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
    IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.